Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedernews.google.com
MOR03087 multiple myeloma - Google News
Get the latest updates from MOR03087 multiple myeloma - Google News directly as they happen.
Follow now < 10 followers
Latest posts
Last updated 9 months ago
How to get clearer test results on monoclonal antibodies - News-Medical.Net
about 1 year ago
How to get clearer test results on monoclonal antibodies News-Medical.Net
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial - The Lancet
over 2 years ago
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed...
[Full text] Novel Experimental Drugs for Treatment of Multiple Myeloma | JEP - Dove Medical Press
about 3 years ago
[Full text] Novel Experimental Drugs for Treatment of Multiple Myeloma | JEP...
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial - The Lancet
over 4 years ago
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple...
With no partner, MorphoSys drops MOR202 in myeloma - BioPharma Dive
almost 6 years ago
With no partner, MorphoSys drops MOR202 in myeloma BioPharma DiveAs part of...
This RSS feed URL is deprecated
over 6 years ago
This RSS feed URL is deprecated, please update. New URLs can be...
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASH Meeting - FierceBiotech
over 8 years ago
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple...
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASH Meeting - b3c newswire
over 8 years ago
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple...
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple Myeloma at ASH Meeting - Yahoo Finance UK
over 8 years ago
MorphoSys Presents Interim Safety, Pharmacokinetic and Efficacy Data for MOR202 in Multiple...